← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Opiant Pharmaceuticals, Inc.
Santa Monica, CA
$7,387,573
Total funding
1
Grants
Funding over time
peak $3M · FY2018–21$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
Funding mix
By agency
NIH$7,387,573 · 1
By mechanism
U01$7,387,573 · 1
Investigators at Opiant Pharmaceuticals, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Development of an intranasal, long duration opioid antagonist to treat opioid overdose$3,035,646
U01 · FY2019 · DA
Development of an intranasal, long duration opioid antagonist to treat opioid overdose$2,551,346
U01 · FY2018 · DA
Development of an intranasal, long duration opioid antagonist to treat opioid overdose$1,800,581
U01 · FY2021 · DA